Document is current
Any future updates will be listed below
-
Authors
Shi, Youwu
Sun, Jing
Du, Feng
Sun, Zhiwei
Yang, Ying
Yu, Jing
Xiao, Yanjie
Sun, Xiaoyu
Zhang, Wen
Zheng, Hongkun
Zhang, Xiaodong
Jia, Jun
-
Funding
Funding for this research was provided by:
Hengrui Innovative Drug Clinical Research Fundation of Chinese Anti-Cancer Association
Hengrui Cancer Research Foundation of Chinese society of Clinical Oncology
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 30 May 2025
First Online: 5 June 2025
Declarations
:
: This study was approved by the Medical Ethics Committee of Peking University Cancer Hospital & Institute, and all patients gave informed consent.
: Not applicable.
: The authors declare no competing interests.
